Wednesday, March 22, 2023
  • Login
CEO North America
  • Home
  • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel
    • Environment
  • Opinion
  • News
  • Multimedia
No Result
View All Result
  • Home
  • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel
    • Environment
  • Opinion
  • News
  • Multimedia
No Result
View All Result
CEO North America
No Result
View All Result

U.S. to pay Pfizer nearly $2 billion for more Paxlovid courses in 2023

in News
U. S. To pay pfizer nearly $2 billion for more paxlovid courses in 2023
Share on LinkedinShare on WhatsApp

The U.S. government agreed to pay Pfizer Inc (NYSE: PFE) nearly $2 billion for an additional 3.7 million courses of its authorized COVID-19 oral treatment, PAXLOVID™ the company said on Tuesday. The new purchase supplements the 20 million courses previously bought by the United States and delivery is planned by early 2023, Pfizer said in a statement.

PAXLOVID™ plays an important role in helping to combat COVID-19-related hospitalizations and death in high-risk patients. The oral treatment is currently authorized for conditional or emergency use in approximately 70 countries across the globe, including the United States. As of Nov. 30, Pfizer had shipped almost 37 million courses of Paxlovid to 52 countries around the world, it said in a statement. That includes all 20 million courses previously ordered by the U.S. government.

The two-drug oral treatment is currently available for free in the United States, where more than 9 million courses have been delivered to pharmacies, and patients have used over 6 million courses of the treatment, according to government data.

Pfizer is expected to top $100 billion in revenue this year, more than half of which is expected to come from its COVID business.

Tags: PfizerPfizer coronavirus vaccinePfizer vaccine

Related Posts

Amazon’s zoox tests robotaxi on public road with employees as passengers
News

Amazon’s Zoox tests robotaxi on public road with employees as passengers

New york regulator orders binance stablecoin backer to stop issuing token
News

New York regulator orders Binance stablecoin backer to stop issuing token

Oil falls on demand fears as fed ‘make or break moment’ approaches
News

Oil falls on demand fears as Fed ‘make or break moment’ approaches

U. S. Consumer prices revised higher in december, november
News

U.S. consumer prices revised higher in December, November

Lyft shares sink after grim forecast shows it falling behind uber
News

Lyft shares sink after grim forecast shows it falling behind Uber

China says proposed u. S. Ban on chinese buying u. S. Property violates market rules
News

China says proposed U.S. ban on Chinese buying U.S. property violates market rules

Yahoo to lay off more than 20% of staff
News

Yahoo to lay off more than 20% of staff

Hyundai in talks with u. S. Labor department over alabama child labor
News

Hyundai in talks with U.S. Labor Department over Alabama child labor

Disney to cut 7,000 jobs in major revamp by ceo iger
News

Disney to cut 7,000 jobs in major revamp by CEO Iger

Elon musk has an active stake in twitter; started buying stock in january
News

Elon Musk to unveil Tesla’s ‘Master Plan 3’ at first investor day

No Result
View All Result

Recent Posts

  • Symbotic’s CEO Rick Cohen shines a light on the consumer goods supply revolutionSymbotic Soars
  • CEO John Wynne outlines how Fortis Solution Group is disrupting the packaging industry
  • CEO Keh-Shew Lu explains how Diodes Inc is pushing the frontiers of connectivity
  • CEO NA Andrea Pirondini explains why the Prysmian Group is best-in-class at cable solutions
  • Eric Clark on how ONE NTT is driving client-led innovation

Recent Comments

    Archives

    Categories

    • Art & Culture
    • Business
    • CEO Interviews
    • CEO Life
    • Editor´s Choice
    • Entrepreneur
    • Environment
    • Food
    • Health
    • Highlights
    • Industry
    • Innovation
    • Issues
    • Management & Leadership
    • Multimedia
    • News
    • Opinion
    • PrimeZone
    • Printed Version
    • Travel
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    • CONTACT
    • GENERAL ENQUIRIES
    • ADVERTISING
    • MEDIA KIT
    • DIRECTORY
    • TERMS AND CONDITIONS

    Editorials – stuart.james@ceo-na.com

    Advertising – media@ceo-na.com

    NEW YORK

    110 Wall St.,
    3rd Floor
    New York, NY.
    10005
    USA
    +1 212 432 5800

     

    MEXICO CITY

    Paseo de la Reforma 296,
    Floor 38
    Mexico City
    06600
    MEXICO

    • CONTACT
    • GENERAL ENQUIRIES
    • ADVERTISING
    • MEDIA KIT
    • DIRECTORY
    • TERMS AND CONDITIONS

    Editorials –
    stuart.james@ceo-na.com

    Editor-In-Chief –

    caroline.sposto@ceo-na.com

    Editorials – editorials@ceo-na.com

    Advertising –
    media@ceo-na.com

    NEW YORK

    110 Wall St.,
    3rd Floor
    New York, NY.
    10005
    USA
    +1 212 432 5800

    MEXICO CITY

    Paseo de la Reforma 296,
    Floor 38
    Mexico City
    06600
    MEXICO

    CEO North America © 2022 - Sitemap

    No Result
    View All Result
    • Home
    • Business
      • Entrepreneur
      • Industry
      • Innovation
      • Management & Leadership
    • CEO Interviews
    • CEO Life
      • Art & Culture
      • Food
      • Health
      • Travel
      • Environment
    • Opinion
    • News
    • Multimedia

    © 2023 JNews - Premium WordPress news & magazine theme by Jegtheme.

    Welcome Back!

    Login to your account below

    Forgotten Password?

    Retrieve your password

    Please enter your username or email address to reset your password.

    Log In

    Warning: array_sum() expects parameter 1 to be array, null given in /home/ceonacom/public_html/wp-content/plugins/jnews-social-share/class.jnews-social-background-process.php on line 111